The "elusive DMOAD": Aggrecanase inhibition from laboratory to clinic.

Malfait, Anne-Marie; Tortorella, Micky D

Malfait, Anne-Marie; Tortorella, Micky D.

Affiliation

Malfait AM; Rush University Medical School, Department of Medicine, Division of Rheumatology, Chicago IL, USA. anne-marie_malfait@rush.edu.
Tortorella MD; Guangzhou Institutes of Biomedical Health, Chinese Academy of Sciences, Guangzhou, China.

Clin Exp Rheumatol ; 37 Suppl 120(5): 130-134, 2019.

Article in En | MEDLINE | ID: mdl-31621572

Subject(s)

ADAM Proteins; Endopeptidases/metabolism; Osteoarthritis/enzymology; Procollagen N-Endopeptidase; ADAM Proteins/antagonists & inhibitors; ADAM Proteins/immunology; ADAMTS4 Protein; Aggrecans/metabolism; Humans; Osteoarthritis/drug therapy; Osteoarthritis/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoarthritis / Endopeptidases / Procollagen N-Endopeptidase / ADAM Proteins Limits: Humans Language: En Journal: Clin Exp Rheumatol Year: 2019 Document type: Article Affiliation country: United States Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links